Sagimet Biosciences Inc. SGMT
9.95 USD +0.26 (+2.68%)
At closeNov 4, 2026, 8:32 AM EST
9.95 0.00 0.00%
Pre-market · Nov 4, 8:32 AM ET
9.66 Day range 10.16
4.50 52-week range 11.45
- YTD
- +68.07%
- 1 year
- +30.75%
Financial health
Altman Z-Score
25.23 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 4
Valuation
P/E -3.7×
FY 2019 5y median -3.7× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 1.7×
FY 2019 5y median 0.9× FY 2025
P/FCF -4.2×
FY 2019 5y median -4.2× FY 2025
EV/EBITDA -3.1×
FY 2019 5y median -3.1× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -23.8%
FY 2019 5y median -23.8% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -45.8%
FY 2019 5y median -29.2% FY 2025
ROIC -51.0%
FY 2019 5y median -41.8% FY 2025
ROA -43.8%
FY 2019 5y median -41.4% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -4.5%
FY 2019 FY 2025
EPS (diluted) -9.0%
FY 2019 FY 2025
Free Cash Flow -7.6%
FY 2019 FY 2025
Financial Health
Current Ratio 22.8×
FY 2019 5y median 22.8× FY 2025
Quick Ratio 22.8×
FY 2019 5y median 22.8× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 0.7×
FY 2019 5y median 1.7× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31